When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 2, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Rakowiecka 36, 02-532 Warszawa.

What is the share capital?

The share capital of the company is PLN 81,100 (approx. $21,907).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company's revenue reached USD 6,255.

Is the company profitable?

No, in 2025 the company was not profitable, reporting a net loss of USD 38,239. For comparison, in 2024 the loss was USD 77,039, meaning the company reduced its loss by 50.5%.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to USD 12,776 in 2025, representing 58% of all operating expenses.

Doto Medicalsp. z o.o. in liquidation

KRS: NIP: REGON:

Overview

Status

Deleted

Activity period

2022-12-02 – 2026-09-14

Activity description

Doto Medical is focused on the development of aptamer technology for targeted filtration of bodily fluids, specifically to remove cytokines and toxins from the blood of patients with chronic kidney disease, during transplantation, and in oncology treatments. The company aims to create filters that can be used with existing organ perfusion devices, dialyzers, and separators. Their products are designed to improve patient outcomes by selectively eliminating harmful molecules while preserving the integrity of other biological components.

Registered address

ul. Rakowiecka 36, 02-532 Warszawa, Poland

Electronic delivery address

AE:PL-68821-48774-EUGRV-13

Financials

Revenue history (in k)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 — this may be an accounting template or the first year of the regime.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs voivodeship

Revenue

This companyUSD 6.25kMedianUSD 155.47kAverageUSD 5.90m

Net profit

This companyUSD -38.24kMedianUSD 2.41kAverageUSD 343.36k

Operating costs

This companyUSD 22.02kMedianUSD 130.86kAverageUSD 5.69m

Assets

This companyUSD 5.44kMedianUSD 162.39kAverageUSD 14.21m

Bank accounts

Registered as a VAT taxpayer on 2023-12-01. Active

mBank
06 1140 1140 0000 2992 6900 1004
mBank
33 1140 1140 0000 2992 6900 1003
mBank
60 1140 1140 0000 2992 6900 1002

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication date	Event
Jan 29, 2026	Liquidation opened

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Beneficial owners

Person	Rights
Tomasz Adam Ciach (61)	Natural person holding a senior management position in a parent entity (e.g. parent company).
Przemysław Daniel Mazurek (50)	Natural person holding a senior management position in a parent entity (e.g. parent company).
Piotr Paweł Mierzejewski (62)	Natural person holding a senior management position in a parent entity (e.g. parent company).

Change history

Date	Event
2026-09-14	PKD change (Added: 72.11.Z, 72.19.Z, 74.90.Z, 77.40.Z, 96.09.Z)
2026-09-14	Struck off the register
2026-08-17	Liquidation ended / withdrawn
2025-12-23	Liquidation opened
2025-07-21	Address change (Legnicka 48e, 54-202, Wrocław → Ul. Rakowiecka 36, 02-532, Warszawa)

FAQ

Last updated: 2026-10-03